annual D&A:
$35.54M+$9.54M(+36.67%)Summary
- As of today (July 5, 2025), RARE annual depreciation & amortization is $35.54 million, with the most recent change of +$9.54 million (+36.67%) on December 31, 2024.
- During the last 3 years, RARE annual D&A has risen by +$22.30 million (+168.47%).
- RARE annual D&A is now at all-time high.
Performance
RARE Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$8.99M-$89.00K(-0.98%)Summary
- As of today (July 5, 2025), RARE quarterly depreciation & amortization is $8.99 million, with the most recent change of -$89.00 thousand (-0.98%) on March 31, 2025.
- Over the past year, RARE quarterly D&A has increased by +$145.00 thousand (+1.64%).
- RARE quarterly D&A is now -0.98% below its all-time high of $9.08 million, reached on December 31, 2024.
Performance
RARE quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$35.69M+$145.00K(+0.41%)Summary
- As of today (July 5, 2025), RARE TTM depreciation & amortization is $35.69 million, with the most recent change of +$145.00 thousand (+0.41%) on March 31, 2025.
- Over the past year, RARE TTM D&A has increased by +$6.07 million (+20.51%).
- RARE TTM D&A is now at all-time high.
Performance
RARE TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
RARE Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.7% | +1.6% | +20.5% |
| 3 y3 years | +168.5% | +119.9% | +155.6% |
| 5 y5 years | +316.2% | +215.2% | +244.8% |
RARE Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +168.5% | -1.0% | +100.6% | at high | +132.9% |
| 5 y | 5-year | at high | +316.2% | -1.0% | +190.8% | at high | +244.8% |
| alltime | all time | at high | >+9999.0% | -1.0% | +8628.2% | at high | >+9999.0% |
RARE Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $8.99M(-1.0%) | $35.69M(+0.4%) |
| Dec 2024 | $35.54M(+36.7%) | $9.08M(+3.7%) | $35.54M(+2.5%) |
| Sep 2024 | - | $8.76M(-1.2%) | $34.68M(+4.7%) |
| Jun 2024 | - | $8.86M(+0.2%) | $33.12M(+11.8%) |
| Mar 2024 | - | $8.85M(+7.6%) | $29.61M(+13.9%) |
| Dec 2023 | $26.01M(+42.7%) | $8.22M(+14.3%) | $26.01M(+14.3%) |
| Sep 2023 | - | $7.19M(+34.1%) | $22.75M(+12.3%) |
| Jun 2023 | - | $5.36M(+2.4%) | $20.25M(+4.5%) |
| Mar 2023 | - | $5.24M(+5.6%) | $19.37M(+6.3%) |
| Dec 2022 | $18.22M(+37.6%) | $4.96M(+5.6%) | $18.22M(+8.5%) |
| Sep 2022 | - | $4.69M(+4.8%) | $16.80M(+9.6%) |
| Jun 2022 | - | $4.48M(+9.6%) | $15.32M(+9.7%) |
| Mar 2022 | - | $4.09M(+15.7%) | $13.96M(+5.4%) |
| Dec 2021 | $13.24M(+8.0%) | $3.53M(+9.9%) | $13.24M(+3.1%) |
| Sep 2021 | - | $3.22M(+3.1%) | $12.84M(+1.0%) |
| Jun 2021 | - | $3.12M(-7.3%) | $12.71M(-0.5%) |
| Mar 2021 | - | $3.37M(+7.5%) | $12.78M(+4.2%) |
| Dec 2020 | $12.26M(+43.6%) | $3.13M(+1.3%) | $12.26M(+8.5%) |
| Sep 2020 | - | $3.09M(-2.9%) | $11.30M(+9.1%) |
| Jun 2020 | - | $3.18M(+11.6%) | $10.35M(+11.6%) |
| Mar 2020 | - | $2.85M(+31.5%) | $9.27M(+8.6%) |
| Dec 2019 | $8.54M(-56.3%) | $2.17M(+1.1%) | $8.54M(-8.3%) |
| Sep 2019 | - | $2.15M(+1.9%) | $9.31M(-19.2%) |
| Jun 2019 | - | $2.11M(-0.6%) | $11.52M(-25.6%) |
| Mar 2019 | - | $2.12M(-28.0%) | $15.50M(-20.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $19.54M(+235.4%) | $2.94M(-32.4%) | $19.54M(+2.2%) |
| Sep 2018 | - | $4.36M(-28.4%) | $19.11M(+20.6%) |
| Jun 2018 | - | $6.08M(-1.3%) | $15.85M(+46.4%) |
| Mar 2018 | - | $6.16M(+145.0%) | $10.82M(+85.8%) |
| Dec 2017 | $5.83M(+70.1%) | $2.51M(+129.6%) | $5.83M(+30.4%) |
| Sep 2017 | - | $1.09M(+3.8%) | $4.47M(+1.5%) |
| Jun 2017 | - | $1.05M(-9.1%) | $4.40M(+9.0%) |
| Mar 2017 | - | $1.16M(+0.3%) | $4.04M(+18.0%) |
| Dec 2016 | $3.42M(+147.4%) | $1.16M(+12.2%) | $3.42M(+24.6%) |
| Sep 2016 | - | $1.03M(+49.0%) | $2.75M(+27.4%) |
| Jun 2016 | - | $692.00K(+27.2%) | $2.16M(+24.9%) |
| Mar 2016 | - | $544.00K(+13.3%) | $1.73M(+24.8%) |
| Dec 2015 | $1.38M(+102.3%) | $480.00K(+8.8%) | $1.38M(+24.0%) |
| Sep 2015 | - | $441.00K(+68.3%) | $1.12M(+28.4%) |
| Jun 2015 | - | $262.00K(+30.3%) | $869.00K(+13.2%) |
| Mar 2015 | - | $201.00K(-5.2%) | $768.00K(+12.3%) |
| Dec 2014 | $684.00K(+54.1%) | $212.00K(+9.3%) | $684.00K(+17.1%) |
| Sep 2014 | - | $194.00K(+20.5%) | $584.00K(+18.0%) |
| Jun 2014 | - | $161.00K(+37.6%) | $495.00K(+13.3%) |
| Mar 2014 | - | $117.00K(+4.5%) | $437.00K(-1.6%) |
| Dec 2013 | $444.00K(+41.9%) | $112.00K(+6.7%) | $444.00K(+33.7%) |
| Sep 2013 | - | $105.00K(+1.9%) | $332.00K(+46.3%) |
| Jun 2013 | - | $103.00K(-16.9%) | $227.00K(+83.1%) |
| Mar 2013 | - | $124.00K | $124.00K |
| Dec 2012 | $313.00K(+820.6%) | - | - |
| Dec 2011 | $34.00K | - | - |
FAQ
- What is Ultragenyx Pharmaceutical annual depreciation & amortization?
- What is the all time high annual D&A for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical annual D&A year-on-year change?
- What is Ultragenyx Pharmaceutical quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical quarterly D&A year-on-year change?
- What is Ultragenyx Pharmaceutical TTM depreciation & amortization?
- What is the all time high TTM D&A for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical TTM D&A year-on-year change?
What is Ultragenyx Pharmaceutical annual depreciation & amortization?
The current annual D&A of RARE is $35.54M
What is the all time high annual D&A for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high annual depreciation & amortization is $35.54M
What is Ultragenyx Pharmaceutical annual D&A year-on-year change?
Over the past year, RARE annual depreciation & amortization has changed by +$9.54M (+36.67%)
What is Ultragenyx Pharmaceutical quarterly depreciation & amortization?
The current quarterly D&A of RARE is $8.99M
What is the all time high quarterly D&A for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high quarterly depreciation & amortization is $9.08M
What is Ultragenyx Pharmaceutical quarterly D&A year-on-year change?
Over the past year, RARE quarterly depreciation & amortization has changed by +$145.00K (+1.64%)
What is Ultragenyx Pharmaceutical TTM depreciation & amortization?
The current TTM D&A of RARE is $35.69M
What is the all time high TTM D&A for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high TTM depreciation & amortization is $35.69M
What is Ultragenyx Pharmaceutical TTM D&A year-on-year change?
Over the past year, RARE TTM depreciation & amortization has changed by +$6.07M (+20.51%)